An End to Leukemia? A Lifesaving Revolutionary Treatment
Stephen Grupp, a physician and lecturer at the University of Pennsylvania School of Medicine, says that due to the treatment of young patients and the aggressive nature of leukemia, the need for new approaches and treatment methods has been successful, and the CTL019 is expected to be available in different